Category Archives: Global News Feed

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company’s Board of Directors, effective immediately. Additionally, Laura J. Hamill has decided to resign from the company’s Board of Directors.

Link:
AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors

ZUG, Switzerland, April 07, 2023 (GLOBE NEWSWIRE) -- Following the U.S. Food and Drug Administration’s decision, Covis Pharma Group (“Covis”) is effectuating the withdrawal of Makena® (hydroxyprogesterone caproate injection), which has been the only treatment approved to reduce the risk of preterm birth in pregnant women who have had a prior spontaneous preterm birth.

See the article here:
Covis Statement on FDA Decision to Withdraw Approval of Makena®

Fifth FDA clearance in less than two years offers greater connectivity and flexibility to improve the patient and provider experience Fifth FDA clearance in less than two years offers greater connectivity and flexibility to improve the patient and provider experience

Originally posted here:
NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities

Regulated Information - Denominator

Continued here:
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

LAKE FOREST, Ill., April 07, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective April 3, 2023, the Compensation Committee of the Company’s Board of Directors granted two newly-hired employees a total of 20,542 restricted stock units (“RSUs”) and 24,018 stock options (“options”).

Follow this link:
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEWS RELEASE – REGULATED INFORMATION APRIL 7, 2023, 4:30 pm ET/ 22:30 CET

Here is the original post:
MDxHealth Shareholder Transparency Declaration